Life Technologies, Fluidigm Reach Licensing Deals, End Litigation
July 07, 2011
Life Technologies, Fluidigm Reach Licensing Deals, End Litigation
Under the cross- and sub-licensing deals, Fluidigm gains access to PCR-related patents from Life Tech, which in return receives access to imaging readers and other technologies from Fluidigm.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Fluidigm Pays Life Tech $2M to Shield Itself from PCR-related Patent Litigation
August 11, 2011 / GenomeWeb Daily News - Life Tech Acquisition Would Make Thermo Fisher a Leader in PCR Research Tools, Forensic Analysis
April 18, 2013 / PCR Insider - Life Tech Launches $30K 'Dedicated' Digital PCR System in Bid to Drive Widespread dPCR Adoption
November 8, 2012 / PCR Insider - Survey Indicates Life Tech Remains Leader of qPCR Research Market, But Faces Some Pricing Pressure
October 25, 2012 / PCR Insider - At First Digital PCR Conference, Enthusiasm Tempered by Realistic Expectations
October 18, 2012 / PCR Insider